- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0112818

About Chemosyn Limited
Data last updated:
Chemosyn Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 1962 and has been in existence for over 64 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1962PLC012310. Its GSTIN is 27AAACC2044D1ZA (Maharashtra). The company holds 13 GST registrations, of which 11 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Chemosyn Private Limited. It is led by directors including Kanhai Samir Shah (Managing Director) and Aanal Samir Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.95 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹19,214 (net margin 0%) and EBITDA of ₹73.65 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 9% over five years.
The company is associated with 1 brand: Chemosyn. As per MCA filings, the company has open charges of ₹4.51 Cr and satisfied charges of ₹8.35 Cr on record. Court records list 38 cases involving the company, including 19 filed by the company and 14 filed against it; 3 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Healkraft Pharma (India) Private Limited with revenue of ₹25.01 Cr. The company has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers.
Chemosyn Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0112818). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemosynltd.com.
Recognitions & Rankings of Chemosyn
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressAkshay Mittal Indl. Premises Cs Ltd Sanjay Bldg. No.5 B Unit No.46 Ground Flr. Andheri, (E), Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Chemosyn Limited
Chemosyn operates one associated brand: Chemosyn. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medicines in India. | chemosynltd.com |
Business Activity of Chemosyn Limited
The main business activity of Chemosyn is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Chemosyn Limited FY 2025 filings available
Chemosyn Limited reported revenue of ₹24.95 Cr (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Chemosyn Limited
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 22% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Chemosyn Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹73.65 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹19,214 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Chemosyn Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chemosyn are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Chemosyn Limited
Chemosyn has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aanal Samir Shah Also directs: Mahabali Intratrade LLP, Ram Doot Intratrade LLP | Whole-Time Director | 18 Jul 2006 | 20 Years 3 Months | Current |
| Kanhai Samir Shah Also directs: Mahabali Intratrade LLP | Managing Director | 13 Dec 2007 | 18 Years 10 Months | Current |
| Madhav Samir Shah Also directs: Ram Doot Intratrade LLP | Director | 13 Dec 2007 | 18 Years 10 Months | Current |
Peer Comparison of Chemosyn Limited
Chemosyn Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healkraft Pharma (India) Private Limited | ₹25.01 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Chennai, Tamil Nadu, India |
| U Square Lifescience Private Limited | ₹24.98 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | Tal Sarkhej Ahmedabad Ii, Gujarat, India |
| Amulya Herbs Private Limited | ₹24.97 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Chandigarh, India |
| Anthus Pharmaceuticals Private Limited | ₹24.97 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Biovitamins Private Limited | ₹24.97 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Bangalore, Karnataka, India |
| Chemosyn Limited this company | ₹24.95 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Mumbai, Maharashtra, India |
| Thrift Pharmaceuticals Private Limited | ₹24.95 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Eucare Pharmaceuticals P Ltd | ₹24.93 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Tamil Nadu, India |
| Pyxus Pharmaceuticals Private Limited | ₹24.91 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Ahmedabad, Gujarat, India |
| Artura Pharmaceuticals Private Limited | ₹24.89 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Chennai, Tamil Nadu, India |
| Greentech Laboratories Private Limited | ₹24.88 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Srikakulam, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Chemosyn by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Chemosyn Limited
Chemosyn Limited is audited by SAMIR M. SHAH & ASSOCIATES. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAMIR M. SHAH & ASSOCIATES. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Chemosyn Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Chemosyn Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Sep 2025 | The Kalupur Commercial Co-Operative Bank Limited | ₹13 Lakh | Open |
| 17 Sep 2025 | The Kalupur Commercial Co-Operative Bank Limited | ₹72 Lakh | Open |
| 11 Feb 2010 | The Kalupur Commercial Co-Operative Bank Limited | ₹1.25 Cr | Open |
| 09 Feb 2010 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.41 Cr | Open |
| 07 Dec 2016 | Others | ₹70 Lakh | Satisfied |
Total charge records: 9 View all charges
Deals & Funding of Chemosyn Limited
Chemosyn Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2008 | Funding round | ₹83.7 Lakh | Investors: Ramdoot Intratrade LLP, Mahabali Intratrade LLP , 2 individuals |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Chemosyn Limited
Chemosyn Limited has 38 court cases on record: 19 filed by Chemosyn, 14 filed against it, 5 where it is another party. 3 cases are pending and 35 are disposed. Status as checked between 28 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 33 | 12 | 1 |
| District courts | 5 | 2 | 2 |
Cases on record (5 of 38)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Union Bank of India Limited | Disposed |
| High Court of Gujarat | Court case (AO) | Filed by the company against Gujarat Industrial Investment Corporation Limited | Disposed |
| High Court of Gujarat | Special civil application | Filed by the company against Gujarat Industrial Investment Corporation Limited | Disposed |
| High Court of Gujarat | Appeal | Filed by the company against Gujarat Industrial Investment Corporation Limited | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed by the company against Gujarat Industrial Investment Corporation Limited | Disposed |
Full case history
All 38 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Chemosyn Limited
Chemosyn Limited has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Laxmi Print Art | •••• | •••• | •••• |
| Omkar Traders | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Futuristic Packaging Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Chemosyn Limited
Employment history and EPFO contributions of people linked to Chemosyn.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Chemosyn Limited
Chemosyn Limited has 8 board changes on record since 2006: 3 appointments and 5 cessations. The latest: Aanal Samir Shah ceased to be Director on 04 Apr 2011.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Chemosyn Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Chemosyn Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Chemosyn Limited
Chemosyn has 13 GST registrations: 11 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACC2044D1ZA | Maharashtra | Active | 01 Jul 2017 |
| 04AAACC2044D1ZI | Chandigarh | Active | 01 Jul 2017 |
| 08AAACC2044D1ZA | Rajasthan | Active | 01 Jul 2017 |
| 09AAACC2044D1Z8 | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Chemosyn Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemosyn Limited
Chemosyn is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 1962 (64+ years old) and is registered under CIN U24239MH1962PLC012310.
Chemosyn reported revenue of ₹24.95 Cr for FY 2025 (down 22% YoY).
Chemosyn has 3 current directors:
- Kanhai Samir Shah - Managing Director
- Aanal Samir Shah - Whole-Time Director
- Madhav Samir Shah - Director
Chemosyn reported a net loss of ₹19,214 (net margin 0%) and EBITDA of ₹73.65 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Chemosyn is -11% over three years and -9% over five years. In the latest year (FY 2025) revenue fell 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Chemosyn is 27AAACC2044D1ZA, registered in Maharashtra. The company has 13 GST registrations in all, of which 11 are active and 2 are cancelled or inactive. Other active GSTINs include 04AAACC2044D1ZI (Chandigarh), 08AAACC2044D1ZA (Rajasthan), 09AAACC2044D1Z8 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Chemosyn is U24239MH1962PLC012310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemosyn has 38 court cases on record: 19 filed by the company and 14 filed against it. 3 are pending. Most are in the high courts.
Chemosyn was incorporated on 27 March 1962, making it 64+ years old. It is registered with the Registrar of Companies, Mumbai.
Chemosyn has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018.
The peers of Chemosyn by revenue are Healkraft Pharma (India) Private Limited, U Square Lifescience Private Limited, Amulya Herbs Private Limited, Anthus Pharmaceuticals Private Limited, Biovitamins Private Limited and 5 more, all in the Pharma industry (Formulations).
Aanal Samir Shah ceased to be Director on 04 Apr 2011. Arvind Balu Thakkar ceased to be Director on 21 Jul 2009. Kanhai Samir Shah ceased to be Additional Director on 27 Sep 2008. Chemosyn has 8 board changes on record in total.